REPETITIVE WEEKLY CYCLES OF INTERLEUKIN-2 .2. CLINICAL AND IMMUNOLOGICAL EFFECTS OF DOSE, SCHEDULE, AND ADDITION OF INDOMETHACIN

被引:125
作者
SOSMAN, JA
KOHLER, PC
HANK, JA
MOORE, KH
BECHHOFER, R
STORER, B
SONDEL, PM
机构
[1] UNIV WISCONSIN,SCH MED,DEPT HUMAN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,SCH MED,DEPT STAT,MADISON,WI 53706
[3] UNIV WISCONSIN,SCH MED,DEPT PEDIAT,MADISON,WI 53706
[4] UNIV WISCONSIN,SCH MED,DEPT GENET,MADISON,WI 53706
关键词
D O I
10.1093/jnci/80.18.1451
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1451 / 1461
页数:11
相关论文
共 51 条
[1]   PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].
ATKINS, MB ;
GOULD, JA ;
ALLEGRETTA, M ;
LI, JJ ;
DEMPSEY, RA ;
RUDDERS, RA ;
PARKINSON, DR ;
REICHLIN, S ;
MIER, JW .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391
[2]   EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].
BELLDEGRUN, A ;
WEBB, DE ;
AUSTIN, HA ;
STEINBERG, SM ;
WHITE, DE ;
LINEHAN, WM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822
[3]   NEPHROTOXICITY OF CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT INTERLEUKIN-2 [J].
CHRISTIANSEN, NP ;
SKUBITZ, KM ;
NATH, K ;
OCHOA, A ;
KENNEDY, BJ .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06) :1072-1075
[4]   THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DENICOFF, KD ;
RUBINOW, DR ;
PAPA, MZ ;
SIMPSON, C ;
SEIPP, CA ;
LOTZE, MT ;
CHANG, AE ;
ROSENSTEIN, D ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :293-300
[5]  
ETTINGHAUSEN SE, 1987, BLOOD, V69, P1654
[6]  
ETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784
[7]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488
[8]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623
[9]   INCREASED VASCULAR-PERMEABILITY IN ORGANS MEDIATED BY THE SYSTEMIC ADMINISTRATION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 IN MICE [J].
ETTINGHAUSEN, SE ;
PURI, RK ;
ROSENBERG, SA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (03) :177-188
[10]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523